Search
moon
sun

T128. Pneumonia in infants and children

A. Etiology

A1. Neonates

(1) group B streptococci
(2) G(-) eneteric bacteria (Klebsiella, E.coli, L. monocytogenes)
(3) S. aureus
(4) S. pneumoniae
(5) S. pyogenes

A2. Infants and children (30days~2yrs)

(1) ๋Œ€๋ถ€๋ถ„ viral (RSV, influenza, parainfluenza, human metapneumovirus, adenovirus)
(2) S. pneumoniae
(3) H. influenzae type b (HIb)

A3. Children (2~5yrs)

(1) ๋Œ€๋ถ€๋ถ„ Viral
(2) S. pneumoniae
(3) H. influenzae type b
(4) Mycoplasma
(5) Chlamydophila pneumoniae

A4. 5~13 yrs

(1) Mycoplasma pneumoniae๊ฐ€ ๊ฐ€์žฅ ํ”ํ•จ
(2) C. pneumoniae
(3) S. pneumoniae
(4) S. aureus
(5) Legionella
(6) M. tuberculosis

A5. Adolescents : ์„ฑ์ธ์—์„œ์™€ ๋น„์Šทํ•œ ์–‘์ƒ์„ ๋ณด์ž„.

โ€ข
๋Œ€๋ถ€๋ถ„ ๊ฒฝ์šฐ์— causative agent๋Š” ๋ชจ๋ฅด๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ๊ณ , definite microbiologic diagnosis๋Š” BAL์ด๋‚˜ pleural effusion์—์„œ culture ๋“ฑ์—์„œ๋‚˜ ๊ฐ€๋Šฅํ•˜๊ณ  ์ด๊ฒƒ์€ ์‘๊ธ‰์‹ค์—์„œ ๋ถˆ๊ฐ€.
โ€ข
Cystic fibrosis ํ™˜์ž : S.aureus (1์‚ด ๋ฏธ๋งŒ), Pseudomonas (์ดํ›„)
โ€ข
Sickle cell disease ํ™˜์ž : Encapsulated bacteria (e.g. Pneumococcus, Salmonella, Klebsiella)
โ€ข
HIV, malignancy, congenital immunodefiencies ํ™˜์ž : Pneumocystis jirovecii,cytomegalovirus,fungi

B. Pathogen-specific patterns of disease

1.
Typical pneumonia (1) ๊ณ ์—ด, ์˜คํ•œ, ํ‰๋ง‰์„ฑ ํ‰ํ†ต, ๊ฐ€๋ž˜๋ฅผ ๋™๋ฐ˜ํ•œ ๊ธฐ์นจ์œผ๋กœ ๋‚˜ํƒ€๋‚œ๋‹ค. (2) S. pneumoniae์™€ ๊ฐ™์€ ์„ธ๊ท ์„ฑ ํ๋ ด์„ ์‹œ์‚ฌํ•œ๋‹ค.
2.
Atypical pneumonia (1) ์ˆ˜์ผ์—์„œ ์ˆ˜์ฃผ์— ๊ฑธ์นœ ์ฆ์ƒ ๋ฐœํ˜„์„ ๋ณด์ด๋ฉฐ, ๋งˆ๋ฅธ๊ธฐ์นจ, ๋ฏธ์—ด, malaise์™€ ๊ฐ™์€ ์ฆ์ƒ์„ ๋ณด์ธ๋‹ค. (2) Mycoplasma๋‚˜ C. pneumoniae ๊ฐ์—ผ ์‹œ์— ๋ณด์ผ ์ˆ˜ ์žˆ๋‹ค.
3.
Staphylococcal pneumonia (1) Influenza ๊ฐ์—ผ์ด ์„ ํ–‰ํ•  ์ˆ˜ ์žˆ๊ณ , ๊ธ‰์†ํ•œ ์ง„ํ–‰์„ ๋ณด์ด๋ฉฐ ๊ณ ์—ด, ๋…์„ฑ, ํ๋†์–‘ ๋“ฑ์˜ ์†Œ๊ฒฌ์„ ๋ณด์ธ๋‹ค.
4.
C. trachomatis ๊ฐ์—ผ์„ ๋ณด์ด๋Š” ์˜์•„ (1) Staccato cough, diffuse rale์ด ๊ด€์ฐฐ๋˜๋‚˜ ๋ฐœ์—ด์€ ์—†์–ด afebrile pneumonitis๋กœ ๋ถˆ๋ฆฌ๊ธฐ๋„ ํ•œ๋‹ค. (2) Older children์—์„œ๋Š” sore throat ๋˜๋Š” dysphagia๋ฅผ ๋ณด์ด๊ธฐ๋„ ํ•œ๋‹ค.
5.
Mycoplasma ๊ฐ์—ผ (1) Hacking, dry cough๋ฅผ ๋ณด์ด๊ณ , ๊ด€์ ˆํ†ต, ํ”ผ๋ถ€๋ฐœ์ง„, CNS ์ฆ์ƒ๊ณผ ๊ฐ™์€ ํ์™ธ ์ฆ์ƒ์ด ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ๋‹ค. (2) (Rosen 8th) ๋“œ๋ฌผ์ง€๋งŒ bullous myringitis๊ฐ€ ๊ด€์ฐฐ๋  ์ˆ˜ ์žˆ๊ณ , ์ด๋Š” mycoplasma ๊ฐ์—ผ์— ํŠน์ง•์ ์ธ ์†Œ๊ฒฌ์ด๋‹ค.
6.
B. pertussis ๊ฐ์—ผ : Whooping cough๊ฐ€ ํŠน์ง•์ ์ด๋‹ค.
7.
์œ„ํ—˜์ธ์ž์— ๋…ธ์ถœ๋œ ์ง€์—ญ์—์„œ ์ง€์†๋œ ๊ธฐ์นจ๊ณผ x-ray ์ƒ ํŠน์ด์ ์ธ ์†Œ๊ฒฌ์ด ์žˆ๋‹ค๋ฉด, tuberculosis๋ฅผ ์˜์‹ฌํ•ด์•ผ ํ•œ๋‹ค.
8.
Unique and high risk group (1) TB (endemic area: Alaska, ์•„ํ”„๋ฆฌ์นด, ์•„์‹œ์•„, ๋™์œ ๋Ÿฝ) (2) Cystic fibrosis (S. aureus<1yo, psudomomans>1yo) (3) Sickle cell anemia (encapsulated bacteria: pneumococus, klebsiella, salmonella) (4) HIV (5) Congenical immunodeficiency (Opportunistic infection : P.jiroveci, CMV, fungus)

C. Diagnosis

1.
๋น ๋ฅธ ํ˜ธํก์€ ํ๋ ด์„ ์ง„๋‹จํ•˜๋Š” ๋ฐ ์žˆ์–ด ๊ฐ€์žฅ ๊ฐ„๋‹จํ•˜๊ณ  ํ‘œ์ค€ํ™”๋œ ์Šคํฌ๋ฆฌ๋‹ ๋„๊ตฌ์ด๋‹ค (Rapid respiratory rate is a simple, standardized, and sensitive screening tool for pneumonia).
2.
Infant ์—์„œ ๊ฐ„ํ—์ ์ธ ๋ฌดํ˜ธํก ๊ทธ๋ ๊ฑฐ๋ฆผ, ์ž˜ ๋จน์ง€ ๋ชปํ•˜๋Š” ๋“ฑ์˜ ์†Œ๊ฒฌ์€ dyspnea๋ฅผ ์‹œ์‚ฌ
3.
๊ฐ€๋ž˜๋ฅผ ๋™๋ฐ˜ํ•œ ๊ธฐ์นจ์€ late childhood ์ด์ „์—๋Š” ๋“œ๋ฌผ๊ฒŒ ๋‚˜ํƒ€๋‚œ๋‹ค.
4.
Room air์—์„œ hypoxia๊ฐ€ ๊ด€์ฐฐ๋˜๋Š” ๊ฒฝ์šฐ ์ด๋Š” radiographic pneumonia์˜ ๊ฐ€์žฅ ๊ฐ•๋ ฅํ•œ ์˜ˆ์ธก์ธ์ž์ด๋ฉฐ, oral amoxicillin ์น˜๋ฃŒ ์‹คํŒจ์˜ ๊ฐ€๋Šฅ์„ฑ์ด ๋†’์•„์ง„๋‹ค.

D. Imaging

1.
์ฆ์ƒ์ด ์‹ฌํ•˜์ง€ ์•Š๊ณ , ํ•ฉ๋ณ‘์ฆ์ด ๋™๋ฐ˜๋˜์ง€ ์•Š์€ ํ•˜๊ธฐ๋„ ๊ฐ์—ผ ํ™˜์•„์—์„œ ๋ฐ˜๋“œ์‹œ imaging study๋ฅผ ์‹œํ–‰ํ•  ํ•„์š”๋Š” ์—†๋‹ค.
2.
Potential indications for chest radiography (1) Toxic appearance and respiratory finding์„ ๋ณด์ด๋Š” ํ™˜์•„ (2) 0~3๊ฐœ์›” ํ™˜์•„์—์„œ ๋ฐœ์—ด์„ ๋™๋ฐ˜ํ•  ๊ฒฝ์šฐ ํŒจํ˜ˆ์ฆ์— ๋Œ€ํ•œ ๊ฒ€์‚ฌ์˜ ํ•˜๋‚˜๋กœ ์ง„ํ–‰ (3) 5์„ธ ๋ฏธ๋งŒ์˜ ํ™˜์•„ BT>39โ„ƒ (l02.2โ„‰), WBC >20,000/mm3, no clear infection source (4) ํ•ฉ๋ณ‘์ฆ์ด ์˜์‹ฌ๋  ๊ฒฝ์šฐ (ํ‰์ˆ˜ ๋˜๋Š” ๊ธฐํ‰ ๋“ฑ) (5) ์น˜๋ฃŒ์— ๋ฐ˜์‘์ด ์—†๋Š” ํ๋ ด (6) Biphasic illness๋ฅผ ๋ณด์ผ ๊ฒฝ์šฐ (์ƒ๊ธฐ๋„ ๊ฐ์—ผ์ด ์„ ํ–‰ํ•œ ํ•˜๊ธฐ๋„ ์ฆ์ƒ๊ณผ ๊ณ ์—ด) (7) ์ด๋ฌผ์งˆ์˜ ํก์ธ์ด ์˜์‹ฌ๋  ๊ฒฝ์šฐ (8) ์„ ์ฒœ์  ํ ๊ธฐํ˜•์ด ์˜์‹ฌ๋  ๊ฒฝ์šฐ (9) โ€œRound pneumonia" ์‹œ ์ข…์–‘์„ฑ ๋ณ‘๋ณ€์„ ๋ฐฐ์ œํ•˜๊ธฐ ์œ„ํ•˜์—ฌ

E. Treatment (โ˜…)

1.
Supplemental Oxygen : Target O2 Sat. >92%
2.
Children์€ mucus ์ œ๊ฑฐ์— cough ์˜์กด์ ์ด๊ธฐ ๋•Œ๋ฌธ์—, ๊ธฐ์นจ ์–ต์ œ์ œ ๋ณดํ†ต ์‚ฌ์šฉํ•˜์ง€ ์•Š๋Š”๋‹ค.
3.
Narcotic-based ๊ธฐ์นจ ์–ต์ œ์ œ older children์—๊ฒŒ ์‚ฌ์šฉ, Codein ํŠนํžˆ ํ˜ธํก ์–ต์ œ ๋•Œ๋ฌธ์— ๋น„์ถ”์ฒœ
4.
Noninfectious pneumonitis (e.g.chemical inhalation, aspiration), Likely viral pneumonia (e.g. 3mo~5yrs, audible wheezing, RSV or influenza+)์˜ ๊ฒฝ์šฐ ๋ณด์กด์  ์กฐ์น˜.
5.
Antibiotics๋Š” viral pneumonia์—์„œ indication ๋˜์ง€ ์•Š๋Š”๋‹ค.
6.
Empiric antibiotic Treatment
(1) Neonates Ampicillin (for โ‘  Listeria, group B streptococcus)
โ€ข
aminoglycoside (gentamicin) or 3rd cephalosporin (cefotaxime) โ‘ก Ceftriaxone์€ neonate์—์„œ bilirubinemia๋ฅผ ์ดˆ๋ž˜ํ•  ์ˆ˜ ์žˆ์–ด ๊ธˆ๊ธฐ
(2) 1~3 mo โ‘  Erythromycin or clarithromycin (for atypical bacteria) โ‘ก Azithromycin ์€ FDA ์Šน์ธ์„ ๋ฐ›์ง€ ๋ชปํ•ด ์‚ฌ์šฉํ•˜์ง€ ์•Š์Œ. (3) >3 mo : High dose amoxicillin (80~100 mg/kg/d) or another ฮฒ-lactam (for S. pneumoniae). (4) >5 yrs โ‘  Macrolides โ‘ก Multiple pathogen ์ด ์˜์‹ฌ๋  ๊ฒฝ์šฐ, ฮฒ-lactam or cephalosporins + macrolide. (5) Macrolide ์— ๋Œ€ํ•œ pneumococcal resistance ๋Š” ์ฆ๊ฐ€ํ•˜๋Š” ์ถ”์„ธ (6) ์†Œ์•„์—์„œ fluoroquinolone ์˜ ์•ˆ์ „์„ฑ์€ ํ™•๋ฆฝ๋˜์ง€ ์•Š์•˜๊ณ , arthropathy ์˜ ์œ„ํ—˜์ด ์žˆ๋‹ค. (7) Doxycycline ์˜ ๊ฒฝ์šฐ, ์˜๊ตฌ์ ์ธ ์น˜์•„ ์ฐฉ์ƒ‰์„ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋‹ค.

F. Complications

1.
Apnea : ์•„์ฃผ ์–ด๋ฆฐ infant์—์„œ RSV, chlamydia, B. pertussis ๊ฐ์—ผ ์‹œ ๋ฐœ์ƒ ๊ฐ€๋Šฅ.
2.
Pleural effusion, empyema, pneumothorax, pneumatocele๊ณผ ๊ฐ™์€ ํ•ฉ๋ณ‘์ฆ์€ H. influenzae type b์—์„œ ์ข€ ๋” ๋ฐœ์ƒํ•œ๋‹ค.
3.
S.aureus๋Š” empyema, abscess, pneumatocele์„ ๋‹ค๋ฅธ ๋ณ‘์›๊ท ์— ๋น„ํ•ด ์ข€ ๋” ์ž˜์ผ์œผํ‚จ๋‹ค.
4.
Mycoplasma๋Š” arthritis, meningitis๋ฅผ ์ผ์œผํ‚ฌ ์ˆ˜ ์žˆ๋‹ค.

G. Disposition